Study demonstrates use of CRi imaging systems in biomarker analysis

12/2/2009 | GenomeWeb Daily News (free registration)

Cambridge Research & Instrumentation conducted a study that shows how its imaging and analysis platform can be used to measure biomarkers of signal pathway activity in intact tissue. The results suggest "a growing role for our optical imaging and analysis technologies in clinical biomarker analysis for developing targeted drug therapies and molecular diagnostics," said Cliff Hoyt, CRi's chief technology officer.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN